We describe methods for the manufacture of large volumes of lipid-based oxygen microbubbles (LOMs) designed for intravenous oxygen delivery using high-shear homogenization and serial concentration.
A subscription to JoVE is required to view this content. Sign in or start your free trial.
Method Article
We describe methods for the manufacture of large volumes of lipid-based oxygen microbubbles (LOMs) designed for intravenous oxygen delivery using high-shear homogenization and serial concentration.
Gas-filled microbubbles have been developed as ultrasound contrast and drug delivery agents. Microbubbles can be produced by processing surfactants using sonication, mechanical agitation, microfluidic devices, or homogenization. Recently, lipid-based oxygen microbubbles (LOMs) have been designed to deliver oxygen intravenously during medical emergencies, reversing life-threatening hypoxemia, and preventing subsequent organ injury, cardiac arrest, and death. We present methods for scaled-up production of highly oxygenated microbubbles using a closed-loop high-shear homogenizer. The process can produce 2 L of concentrated LOMs (90% by volume) in 90 min. Resulting bubbles have a mean diameter of ~2 μm, and a rheologic profile consistent with that of blood when diluted to 60 volume %. This technique produces LOMs in high capacity and with high oxygen purity, suggesting that this technique may be useful for translational research labs.
Microbubbles composed of protein, polymer, and lipid shells have been developed as vectors for drug delivery, gene therapy, and ultrasound contrast agents1-5. Because these therapeutic uses require intravascular microbubble persistence, such microbubbles are commonly filled with inert, high molecular-weight gases such as perfluorocarbons6, which have low solubility in blood and stabilize the bubble3,4.
Recently, lipid-based oxygen microbubbles (LOMs) have been designed to deliver therapeutic doses of oxygen, which may preserve end-organ oxygen delivery and prevent hemodynamic instability during periods of ai....
Access restricted. Please log in or start a trial to view this content.
1. System Set-up
The system consists of a holding and concentrating tank (HCT) fitted with a single stage mixer, an in-line high shear homogenizer, a roller pump to move fluid between the HCT and the homogenizer, and a heat-exchanger (Figure 1).
Access restricted. Please log in or start a trial to view this content.
High shear homogenization enables the efficient (i.e. within one afternoon) production of sufficient LOMs for an animal study and does not require technical expertise. Once proficient, up to 2 L of concentrated LOMs can be manufactured in 90 min.
Microbubble size and morphology was assessed by light microscopy and by light obscuration. When a 10 μl sample of LOMs was visualized, spherical LOMs were noted, as well as a relative paucity of lipid debris (Figure 3A). This.......
Access restricted. Please log in or start a trial to view this content.
The most important steps to creating concentrated, highly oxygenated LOMs include: 1) ensuring that the headspace within the HCT remains fully oxygenated; 2) ensuring that the purity of the lipid excipients is optimal (including storage conditions and use of GMP products); 3) ensuring that the powdered lipids mix completely with the aqueous phase prior to priming the system; and 4) paying close attention to the increase in gas fraction within the HCT to ensure that the volume fraction of gas does not exceed 70%.
Access restricted. Please log in or start a trial to view this content.
The authors declare that they have no competing financial interests.
Funding: U.S. Army Medical Research & Materiel Command (USAMRMC) and managed by the Telemedicine & Advanced Technology Research Center. Shunxi Ji contributed the modification of the syringes as described here.
....Access restricted. Please log in or start a trial to view this content.
| Name | Company | Catalog Number | Comments |
|---|---|---|---|
| 1,2-distearoyl-sn-glycero-3-phosphocholine (DSPC) | Avanti Polar Lipids | 770365 | Alternate product: non-GMP from NOF America (Coatsome MC-8080) |
| Cholesterol | Sigma Aldrich | C75209 | |
| Plasma-Lyte A | VWR | 80089-818 | Alternatively can use NaCl |
| Glass collection vessel | Specialty Glass, Inc. | Custom | Contact: Pam Zurbrick - 281-595-2210 |
| Gas composition (oxygen) monitor | Precision Medical | PM5900L | |
| Sarns 8000 roller pump | Calicut Medical | 16407 | Part of a modular perfusion system |
| BIOtherm Heat Exchanger | Medtronic | ECMOtherm-II | |
| Verso laboratory in-line mixer | Silverson Machines, Inc | TH-IL-102-VERSO | Use multistage workheads and front-end extension with T piece |
| T-piece for Silverson Verso inlet port | Process Innovations | Custom | Contact: Brian Leavitt - 508-423-2266 |
| L5M-A laboratory mixer | Silverson Machines, Inc | NC0136483 | Use mesh emulsor screen (fine) |
| Rochester-Ochsner toothed forceps | Fisher Scientific | 13-812-18 | |
| 140 ml syringe | Kendall Healthcare Monoject | 8881114030 | Ensure there is a luer lock. |
| IX71 Inverted light microscope | Olympus | IX71 | |
| Retiga-2000R microscope camera | QImaging | RET-2000R-F-M-12 | |
| Accusizer 780A Autodilution | PSS-NICOMP Particle Sizing Systems | Out of production |
Access restricted. Please log in or start a trial to view this content.